@article{oai:hirosaki.repo.nii.ac.jp:00003751,
 author = {Narumi, Shunji and Murakami, Reiichi and Hatakeyama, Shingo and Fujita, Tadashi and Koie, Takuya and Yoneyama, Takahiro and Kudo, Shigemasa and Kamimura, Noritaka and Mori, Kazuyuki and Shimada, Michiko and Nakamura, Norio and Umehara, Minoru and Saito, Hisao and Okumura, Ken and Hakamada, Kenichi and Ohyama, Chikara},
 issue = {2-4},
 journal = {弘前医学},
 month = {Nov},
 note = {Introduction Kidney transplantation has been widely accepted as a definitive therapy for patients with renal failure. The Hirosaki Kidney Transplant Unit was organized in June 2006 in conjunction with the Departments of Urology, Cardiology, Respiratory Medicine and Nephrology, and Gastrointestinal Surgery, from the Hirosaki University School of Medicine. Herein, we introduce our current results and discuss our future strategies. Patients and Methods From June 2006 to December 2011, 36 kidney transplants were performed with 31 living donors and 5 deceased donors. Immunosuppression therapy included an inductor treatment of anti-CD25 antibody and
triple therapy with calcineurin inhibitor, mycophenolate mofetil, and steroids. Results Recipients included 25 males and 11 females. The patients’ average age was 41.8 years. Nine living–pairs were ABO incompatible. Deceased donors were performed at Oyokyo Hospital. Median follow-up period was 27.6 months. Acute cellular rejection occurred in 8.3% of patients. Positive antigenemia for cytomegalovirus happened in 16.7% of patients, but none developed invasive diseases. All recipients are currently surviving. Graft survival rates at 1, 3, and 5 years are 100%, 94.7%, and 94.7%, respectively. Conclusion Successful kidney transplantations have been performed by a multidisciplinary unit at Hirosaki University. Our next step is a promotion to increase organ donation., 弘前医学. 63, 2012, p.136-142},
 pages = {136--142},
 title = {Kidney Transplantation at Hirosaki Kidney Transplant Unit-Initial 5-Year Experience},
 volume = {63},
 year = {2012}
}